Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential

被引:46
作者
Hu, SJ
Guo, XN
Xie, HH
Du, YL
Pan, YL
Shi, YQ
Wang, J
Hong, L
Han, S
Zhang, DT
Huang, DW
Zhang, KD
Bai, FH
Jiang, HP
Zhai, HH
Nie, YZ
Wu, KC
Fan, DM [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, State Key Lab GI Canc Biol, Xian 710032, Shanxi, Peoples R China
[2] Ningxia Med Coll, Peoples Hosp 1, Yinchuan 750001, Ningxia Hui, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; liver metastasis; phage display; peptide;
D O I
10.1016/j.bbrc.2006.01.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Organ-specific metastasis is an important character of cancer cells. Cancer cells that can metastasize to a special organ were thought to have different proteins in cell membrane, which might have potential utility as diagnostic markers and therapeutic targets. In the present work, based on high liver-metastatic gastric cancer cells, XGC9811-L, a screening approach with phage displayed peptide library, was successfully used to isolate 8-mer peptide ligands binding to the target cells. The phage20 had the highest binding efficiency to XGC9811L cells, which also displayed remarkable cell specificity. Peptide20 that was displayed on phage20 could suppress the motility and invasion of XGC981-L significantly. The adhesive ability of XGC9811-L to collagen W was also inhibited by peptide20. Furthermore, phage20 could significantly reduce the incidence of liver metastasis of gastric cancer transplanted into nude mice and was also beneficial for the reduction the number of metastatic nodles in the liver. In conclusion, the phage display is an effective method to screen for the new molecules associated with organ-specific metastasis. The selected peptide20 can reverse the liver metastasis behavior of the gastric cancer cells. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:964 / 972
页数:9
相关论文
共 29 条
[1]
[白飞虎 Bai Feihu], 2003, [第四军医大学学报, Journal of the Fourth Military Medical University], V24, P873
[2]
Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer [J].
Bao, LR ;
Loda, M ;
Janmey, PA ;
Stewart, R ;
AnandApte, B ;
Zetter, BR .
NATURE MEDICINE, 1996, 2 (12) :1322-1328
[3]
Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries [J].
Barry, MA ;
Dower, WJ ;
Johnston, SA .
NATURE MEDICINE, 1996, 2 (03) :299-305
[4]
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis [J].
Binétruy-Tournaire, R ;
Demangel, C ;
Malavaud, B ;
Vassy, R ;
Rouyre, S ;
Kraemer, M ;
Plouët, J ;
Derbin, C ;
Perret, G ;
Mazie, JC .
EMBO JOURNAL, 2000, 19 (07) :1525-1533
[5]
Medicine - Tracing the steps of metastasis, cancer's menacing ballet [J].
Couzin, J .
SCIENCE, 2003, 299 (5609) :1002-+
[6]
Critical determinants of cancer metastasis: rationale for therapy [J].
Fidler, IJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) :S3-S10
[7]
Fukuda MN, 2000, CANCER RES, V60, P450
[8]
FURUKAWA T, 1993, CANCER RES, V53, P1204
[9]
Analysis of experimental liver metastasis from tumors inoculated in the mouse stomach cavity [J].
Gunji, Y ;
Yol, S ;
Suzuki, T ;
Hori, S ;
Hayashi, H ;
Shimada, H ;
Matsubara, H ;
Nabeya, Y ;
Ochiai, T .
SURGERY TODAY, 2002, 32 (02) :142-147
[10]
An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery [J].
Harbottle, RP ;
Cooper, RG ;
Hart, SL ;
Ladhoff, A ;
McKay, T ;
Knight, AM ;
Wagner, E ;
Miller, AD ;
Coutelle, C .
HUMAN GENE THERAPY, 1998, 9 (07) :1037-1047